Larry D. Alphs, MD, PhD | Psychiatrist.com

Earlier Use of Paliperidone Palmitate in Patients With Schizophrenia

Original Research

Earlier Use of Paliperidone Palmitate in Patients With Schizophrenia

September 25, 2023

Long-acting injectable antipsychotics (LAIs) are typically reserved for patients with a long history of schizophrenia. This analysis of 3 studies found benefit in initiating the LAI paliperidone palmitate earlier...

Oliver J. Lopena, Larry D. Alphs, Martha Sajatovic, et al

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

August 16, 2010

Roger E. Meyer, Carl Salzman, Eric A. Youngstrom, et al

Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

July 13, 2010

Roger E. Meyer, Carl Salzman, Eric A. Youngstrom, et al

Article

Clozapine: The Commitment to Patient Safety

December 1, 1999

Larry D. Alphs, Ravi Anand